Efficacy of adalimumab, etanercept, and infliximab in psoriatic arthritis based on ACR50 response after 24 weeks of treatment

V. Brodszky, M. Pentek, L. Gulacsi

Research output: Contribution to journalLetter

11 Citations (Scopus)
Original languageEnglish
Pages (from-to)399-400
Number of pages2
JournalScandinavian Journal of Rheumatology
Issue number5
Publication statusPublished - Oct 6 2008

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this